XWXinyan Wang

Xinyan Wang

*This is an algorithmically generated author record based on publicly available information.

Xinyan Wang has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Chen

    Nanjing Women and Children’s Healthcare Institute, Women’s Hospital of Nanjing Medical University, Nanjing Women and Children’s Healthcare Hospital , Jiangsu

    3 shared publications
  • Qianqian Lu

    Department of Obstetrics, Women’s Hospital of Nanjing Medical University, Nanjing Women and Children’s Healthcare Hospital , Jiangsu

    3 shared publications
  • Aiwen Wu

    Department of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University , Beijing

    2 shared publications
  • Bing Zhu

    HuaZhong University of Science and Technology, Wuhan, Hubei, China

    2 shared publications
  • Chen Yan

    Nanjing Women and Children’s Healthcare Institute, Women’s Hospital of Nanjing Medical University, Nanjing Women and Children’s Healthcare Hospital , Jiangsu

    2 shared publications
  • Peng Guo

    Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

    2 shared publications

Latest Publications

  • Vaginal Escherichia coli infection impairs ovarian homeostasis: phenotypic characterization and mechanistic insights

    by Pingping Lin, Qianqian Lu, Xiaojing Hou, Jie Chen, Chen Yan, Aiwen Wu, Huimin Fan, Xinyan Wang, Zhen Zeng

    Premature ovarian insufficiency (POI), a condition characterized by the loss of ovarian function before the age of 40, has emerged as a critical contributor to declining global fertility rates and the increasing prevalence of female infertility. Growing epidemiological evidence suggests that reproductive tract infections may represent a previously underappreciated risk factor for POI development, although the underlying mechanisms remain unclear. This study established a mouse model of chronic vaginal Escherichia coli (E. coli) infection to systematically investigate the potential impacts and underlying mechanisms of long-term vaginal E. coli infections on ovarian function, with particular focus on vaginal microbiota homeostasis and female reproductive health. Our study observed that long-term vaginal E. coli infection significantly impairs reproductive function of mice, manifesting as reduced fertility with diminished offspring production, concurrent with disrupted estrous cycle and impaired ovarian endocrine function. The infection caused significant ovarian reserve depletion, characterized by reduced primordial follicle counts accompanied by increased numbers of atretic follicles, as well as diminished follicular quality. Mechanistically, over-activation of the PI3K–mTORC signaling pathway was identified as a key driver of primordial follicle pool exhaustion, thereby accelerating ovarian reserve decline. These findings establish chronic reproductive tract infections as a modifiable risk factor for ovarian dysfunction, highlighting the importance of infection screening in fertility preservation strategies and paving the way for future research into microbiota-based interventions for maintaining ovarian health.

  • Open Access

    Comparative effectiveness and safety of nifedipine and magnesium sulfate as treatment options for preterm birth: a systematic review and meta-analysis

    by Jianing Fan, Qianqian Lu, Jie Chen, Pingping Lin, Chong Fan, Juan Lyv, Yuhan Zhang, Xinyan Wang

    Objectives Preterm birth (PTB) is a major cause of neonatal morbidity and mortality worldwide. Effective use of tocolytic agents may improve perinatal outcomes. This study aims to compare the effectiveness and safety of nifedipine and magnesium sulfate in the treatment of PTB. Design A systematic review and meta-analysis. Data sources China National Knowledge Infrastructure, China Science and Technology Journal Database, WanFang, PubMed, Embase, Web of Science and Cochrane were searched from inception to 1 December 2024. Eligibility criteria We included randomised controlled trials (RCTs) and cohort studies that compare the efficacy and safety of magnesium sulfate versus nifedipine in treating PTB. Data extraction and synthesis Two researchers independently screened studies and extracted data. Risk of bias was assessed using the Cochrane risk-of-bias assessment tool for RCTs and the modified Newcastle-Ottawa Scale for non-randomised studies. Meta-analysis was conducted using Review Manager V.5.4. Results In all, 50 articles were included in this review, comprising 6072 cases (n=3014 for the magnesium sulfate group; n=3058 for the nifedipine group). Compared with the magnesium sulfate group, the nifedipine group was more favourable in terms of time to onset of action and prolongation of days of gestation, as well as higher neonatal 1 min Apgar scores. The use of magnesium sulfate was associated with a higher incidence of maternal side effects, specifically tachycardia, flushing, palpitations, dizziness and nausea. In addition, the magnesium sulfate group also showed a higher incidence of neonatal respiratory distress syndrome than the nifedipine group. Conclusion Compared with magnesium sulfate, nifedipine is more effective with a faster onset of action and a longer prolonging pregnancy. Additionally, nifedipine may be safer for fewer maternal side effects and better neonatal outcomes. Further studies are needed to confirm the long-term safety and efficacy of these treatments.


  • Effects of emotions on IVF/ICSI outcomes in infertile women: a systematic review and meta-analysis

    by Qianqian Lu, Yun Cheng, Zhi Zhou, Jianing Fan, Jie Chen, Chen Yan, Xin Zeng, Juan Yang, Xinyan Wang

    To assess whether infertile women’s psychological conditions, such as depression, anxiety, and stress, are associated with in vitro fertilization (IV


  • 17β-Estradiol Mediates Staphylococcus aureus Adhesion in Vaginal Epithelial Cells via Estrogen Receptor α-Associated Signaling Pathway

    by Lina Yan, Can Rui, Bin Zhuang, Xia Liu, Ting Luan, Lisha Jiang, Zhiyong Dong, Qing Wang, Aiwen Wu, Ping Li, et al.

    Staphylococcus aureus, a major opportunistic pathogen in aerobic vaginitis (AV), can potentially invade the host and occasionally cause infections. Estrogen is associated with an altered immune response of vaginal epithelial cells and prevention of certain vaginal infectious diseases. However, the molecular mechanisms involving estrogen and S. aureus adhesion to vaginal epithelial cells remain unclear. Thus, here, VK2/E6E7 vaginal epithelial cells were infected with S. aureus, and the role of the estrogen receptor α-associated signaling pathway (ERα/FAK/Src/iNOS axis) in S. aureus adhesion was evaluated. The estrogen-associated phosphorylation status of ERα, FAK, and Src and the protein level of iNOS were assessed by western blotting. We used a specific ERα inhibitor to validate the involvement of the ERα-associated signaling pathway. The results showed that with exposure to 1 nM estrogen for 24 h, transient ERα-associated pathway activation was observed, and the protein expression upregulation was accompanied by a dose-dependent increase in 17-β-estradiol (E2) content and increased S. aureus adherence to vaginal epithelial cells. Estrogen-induced activation of the ERα/FAK/Src/iNOS axis was notably inhibited by the specific ERα inhibitor (ICI 182780). Simultaneously, a significant decrease in the number of adherent S. aureus was observed. However, this inhibitory effect diminished after inhibitor treatment for 24 h. Our findings suggested that the ERα-associated signaling pathway might be involved in S. aureus adherence to vaginal epithelial cells, which appeared to be linked to enhanced cell adhesion leading to AV.


  • Open Access

    A Study on Residents' Satisfaction of "Healthy Houses" in Cities under the Background of Healthy China——Take Suzhou Industrial Park as an example

    by Jinglan Gong, Sitian Xu, Xinxi Song, Yuyi Dai, Juan Zhao, Siyu Shi, Xinyan Wang

    This paper takes Suzhou Industrial Park as the research case, collects data through residents' questionnaires, and constructs a structural equation model to explore residents' satisfaction with "healthy house" and its influencing factors, in order to provide reference for better construction of "healthy house".The research draws the following conclusions: 1. Residents' overall satisfaction with the "health cabin" is 70.46%, which is relatively high; 2. The residents are highly satisfied with the blood pressure meter, temperature detector, opening time and frequency of the "Health House", but are less satisfied with the publicity work, lectures and propaganda activities of the "Health House"; 3. Policy factors have a positive impact on hardware environment satisfaction and hardware environment satisfaction; 4. Objective factors have a positive impact on software environment satisfaction and hardware environment satisfaction.

  • Open Access

    Abstract 6175: Developing antibody-drug conjugates against cholangiocarcinoma using a novel molecular target

    by Bing Zhu, Shi-Li Yao, Xin-Yan Wang, Rui Xu, Peng Guo, Jie-Er Ying

    As a rare malignancy, cholangiocarcinoma (CCA) is a lethal disease with a 5-year overall survival rate of merely 5%. Highly invasive and asymptomatic characteristics of CCA cause most patients diagnosed at advanced stages, severely deteriorating their clinical outcomes. The drug treatment options for CCA are limited and surgical resection of CCA frequently suffers from a high recurrence rate of 66%. Albeit Pemigatinib, a FGFR2 inhibitor, has recently been approved by FDA as the first CCA-targeted therapeutic, only less than 10% of patients with CCA carry FGFR2 fusion mutations that can benefit from this drug. Ivosidenib, another targeted drug against IDH1 mutation, only works for 13% CCA patients carrying this mutation. Therefore, discovering new molecular targets and developing associated targeted drugs remain a significant and unmet medical need in CCA therapy. In this study, we first screened potential molecular targets for CCA by comparing the expression levels of a panel of cancer-related cell membrane antigens between human CCA cells and normal human intrahepatic biliary epithelial cells through flow cytometry. CD54 was identified as a remarkable molecular target of CCA with strong binding force to its antibodies and high endocytosis efficiency by flow cytometry and confocal fluorescent microscopy. Meanwhile, we confirmed that CD54 was absent in most normal human tissues but was highly upregulated in CCA tumor tissues through immunohistochemical (IHC) staining. Based on this newly discovered CCA target, we constructed a series of CD54 antibody-drug conjugates (ADCs) using different chemical linkers and payloads. We next evaluated and compared the half maximum inhibitory concentrations (IC50s) of each ADC in ablating human CCA cells in vitro in order to identify an optimized ADC formulation. Furthermore, we validated its anti-tumor efficacy against primary and peritoneal metastatic CCA tumors in vivo in comparison with conventional chemotherapy. Eventually, we determined the biodistribution and safety profile of this CD54 ADC in order to ensure that it is well-tolerated under the effective dose. In general, we identified CD54 as a novel molecular target for CCA through antibody library screening, and explored its potential in the development of CCA-targeted ADCs, providing a promising targeted therapeutic for clinical treatment of CCA. Citation Format: Bing Zhu, Shi-Li Yao, Xin-Yan Wang, Rui Xu, Peng Guo, Jie-Er Ying. Developing antibody-drug conjugates against cholangiocarcinoma using a novel molecular target [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 6175.

  • Open Access

    Abstract 6174: Developing a novel antibody drug conjugate against cervical cancer

    by Shili Yao, Bing Zhu, Xinyan Wang, Rui Xu, Tong Yang, Peng Guo, Huarong Tang, Tao Zhu

    Background: Cervical cancer ranks fourth in incidence and mortality among female tumors, with over 0.6 million patients diagnosed worldwide in 2020. A large percentage of cervical cancer patients will develop advanced diseases (stage IV or recurrent disease) and the 5-year survival rate of these patients was only 15-20% due to the lack of efficacy and adverse effects of first line chemodrugs. Recently, antibody drug conjugates (ADCs) emerge as a novel class of targeted therapeutics that selectively ablate tumor cells without damaging normal organs and tissues, which has shown promising efficacy in treating solid tumors. In this study, we sought to develop a cervical cancer-targeted ADC using a novel molecular target. Methods: Firstly, human cervical cancer and paracancerous tissue were stained by immunohistochemistry (IHC) in order to determine the difference of the expression level of a molecular target. Three human cervical cancer cell lines (C-33A, Si-Ha and Ca-Ski) and one normal cervical cell line (HCerEpiC) were used to determine the subcellular location of an ADC target on the cells by immunofluorescence (IF) staining, flow cytometry and single photon confocal microscopy. Secondly, endocytosis capability of target antibodies was visualized by confocal imaging and was quantified by flow cytometric analysis. Furthermore, a panel of ADC formulations with different chemical linkers and payloads were designed, constructed and characterized as ADC candidates for cervical cancer therapy. We next evaluated in vitro inhibitory activity of these ADC candidates on three cervical cancer cell lines by CCK8 assay. Finally, orthotopic and lung metastasis animal models of cervical cancer were established to determine the in vivo inhibitory activity and biosafety of constructed ADC candidates. Results: IHC staining of clinical specimens showed that the expression level of CD54 in cervical tumor tissues was significantly higher than those of paracancerous tissues. Fluorescence imaging and flow cytometry further determined the overexpression level, plasma membrane location and antigen-mediated endocytosis activity of CD54 in multiple human cervical cancer cell lines. Among several ADC formulations, an optimized CD54-targeted ADC linker and warhead combination was identified by comparing its IC50 with other ADC candidates and standard-of-care chemodrugs for cervical cancer. The optimized CD54 ADC exhibited promising anti-tumor activity on primary and lung metastatic cervical tumor models. Conclusion: In our study, we identified CD54 as a novel ADC target for cervical cancer. An optimized CD54-targeted ADC formulation was determined and its anti-tumor activity and biosafety profile were determined in multiple human cervical cancer cell lines in vitro and orthotopic and lung metastatic cervical tumor models in vivo, providing a promising targeted therapeutic candidate for the targeted treatment of cervical cancer. Citation Format: Shili Yao, Bing Zhu, Xinyan Wang, Rui Xu, Tong Yang, Peng Guo, Huarong Tang, Tao Zhu. Developing a novel antibody drug conjugate against cervical cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 6174.

  • Computed tomography and histopathological evaluation of osteitis in rabbit models with rhinosinusitis

    by Yi Dong, Bing Zhou, Xiangdong Wang, Zhenxiao Huang, Mingjie Wang, Yunchuan Li, Hongrui Zang, Erzhong Fan, Ying Li, Xinyan Wang

    Conclusions: There is clear correspondence between HU and histopathological evaluation of osteitis. It is feasible to evaluate bone remodeling in rabbit models with rhinosinusitis by measuring the HU. Objective: The objective of this study was to determine whether the HUs of rabbit CRS models can be used to objectively evaluate the degree of osteitis. Methods: Sixty rabbit models were inoculated with staphylococcus aureus. The rabbits were divided into three groups. Each group was divided into a medication administration team and a control team. The HU of the bone in each image was measured. All of the animals were executed after the CT exam. The samples for the mucous and bone changes using light microscope observation were scored. These scores and the HU measurements were compared to the actual bone remodeling over time to examine whether we could evaluate bone remodeling by measuring the HU. Results: The average HU scores in Groups A, B, and C were significantly higher than those of normal rabbits (p < .05). The mucous and bone scores increased as the experimental period lengthened (p = .042, 0.002). HU correlated with the mucous and bone scores in rabbit models with rhinosinusitis (coefficient r = .830, 0.641, 0.586, p = .000).